OCCUDO QUANTITATIVE STRATEGIES LP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
OCCUDO QUANTITATIVE STRATEGIES LP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$78,000
-29.1%
88,9390.0%0.01%
-33.3%
Q1 2022$110,000
-36.4%
88,939
-0.0%
0.01%
-40.0%
Q4 2021$173,000
-32.9%
88,940
-5.4%
0.02%
-51.6%
Q3 2021$258,00094,0090.03%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 20,000$14,0000.02%
Hartford Financial Management Inc. 16,000$11,0000.00%
RBF Capital, LLC 25,000$19,0000.00%
Koshinski Asset Management, Inc. 20,000$14,0000.00%
Financial Advocates Investment Management 23,097$16,0000.00%
D.A. DAVIDSON & CO. 110,000$76,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 162,714$112,0000.00%
HighTower Advisors, LLC 132,328$91,0000.00%
Virtu Financial LLC 15,854$11,0000.00%
BlackRock Inc. 31,631$22,0000.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders